
Opinion|Videos|November 19, 2025
Enhancing Support and Care Coordination in mCRC
Panelists discuss how support networks and coordinated care are essential for delivering third-line metastatic colorectal cancer therapies effectively in the community.
Advertisement
Episodes in this series

Panelists stress the importance of support structures, including guidance from academic institutions, professional networks, and patient advocacy groups, in expanding access to third-line therapies.
They note that effective coordination among oncologists, pharmacists, and other providers is vital to ensure safe and seamless care transitions for patients.
This collaborative approach helps optimize patient outcomes while reducing barriers to therapy initiation and adherence.
Advertisement
Related to this article

Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.

Non-CF bronchiectasis prevalence rose across commercial, Medicare, and Medicaid plans from 2016 to 2024, while incidence stayed relatively stable.

Shorter telomere length was linked to a usual interstitial pneumonia pattern (UIP) on CT in patients with ILD, per research presented at CHEST 2026.

Low awareness that fatty liver can silently progress and that MASH fibrosis is treatable drives missed follow-up testing, says Rohit Loomba, MD.

The FDA approved asundexian (Sunharbo) with antiplatelet therapy to reduce recurrent stroke risk after noncardioembolic stroke or high-risk TIA.
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms
3
Study Finds Possible Deep Endometriosis in 7% of Postmenopausal Women
4
US Measles Outbreaks Cost Nearly $83 Million in 2026
5

